Development Archives | PharmaShots

Eisai Terminates its Worldwide Development & Commercialization Agreement with Purdue Pharma for Lemborexant

May 2, 2019May 6, 2019Tuba Khan

Shots: Purdue to receive one-time payment from Eisai, while releasing itself from rights to develop & commercialize lemborexant. Eisai acquires WW development and [...]

Perelman School of Medicine Signs a Research and Development Agreement with Sensus Healthcare for its Sculptura Intraoperative Radiation Therapy System

April 24, 2019April 29, 2019Tuba Khan

Shots: The Perelman School of Medicine at the University of Pennsylvania & Sensus Healthcare enter into a research & development agreement for Sculptura [...]

Roivant Launches Cytovant Sciences to Collaborates with Medigene for the Development of Cellular Therapies in Asia

April 5, 2019April 24, 2019Tuba Khan

Shots: Medigene to receive $10M upfront, $1B as development, regulatory, and commercial milestones & royalties on sales of four products in multiple indications. [...]

AstraZeneca Signs Development and Commercialization Agreement with Kyowa Hakko Kirin for its Fasenra (beralizumab)

March 26, 2019April 24, 2019Tuba Khan

Shots: Kyowa Kirin to receives upfront, regulatory & commercial milestones. AstraZeneca to get global rights to develop & commercialize Fasenra (beralizumab) for all [...]

Merck Extends its Strategic Collaboration with NGM Biopharmaceuticals

March 22, 2019April 24, 2019Tuba Khan

Shots: Merck exercises its option to extend its Feb,2015 agreement with NGM for development and commercialization of novel biologics therapies. NGM to receive [...]

Shionogi Signs Development & Commercialization Agreement with Akili for its AKL-T01 and AKL-T02 for ADHD & ASD

March 8, 2019April 24, 2019Shiwani Sharma

Shots: Akili to receive $20M upfront, $105M as development & commercialization milestones, making the total the deal value $125M & royalties on sales [...]

BeiGene and Ambrx Enters into a Worldwide Research and Development Collaboration to Develop Novel Biologics

March 7, 2019April 24, 2019Shiwani Sharma

Shots: Ambrx will receive $475M as a total deal value including $29M upfront for research & other programs, $446M as development, regulatory & [...]

Alvogen Expands Development and Commercialization Collaboration with Pfenex for PF708 in EU, MENA and ROW

March 1, 2019April 24, 2019Shiwani Sharma

Shots: Pfenex to receive $2.5M as upfront and milestones for EU & MENA, milestones for ROW & 60% profit split on sales. Alvogen’s [...]

Eurofarma Signs an Exclusive Development and Commercialization Agreement with NLS-1 Pharma for its Nalazol Therapy

February 22, 2019April 24, 2019Shiwani Sharma

Shots: Eurofarma to get exclusive license rights to develop and commercialize NLS-1 Pharma’s Nalazol Therapy in Central & South America and to take [...]

Janssen (J&J) Signs an Exclusive WW Research Collaboration with Morphic to Develop Human Integrins Therapies

February 22, 2019April 24, 2019Shiwani Sharma

Shots: Morphic to receive upfront, $725M milestones, and royalties on WW sales of products. Janssen to get exclusive option to license integrin therapies [...]